Abstract |
|
Authors | A S Yamashita, G S Baia, J S Y Ho, E Velarde, J Wong, G L Gallia, A J Belzberg, E T Kimura, G J Riggins |
Journal | Journal of neuro-oncology
(J Neurooncol)
Vol. 118
Issue 1
Pg. 83-92
(May 2014)
ISSN: 1573-7373 [Electronic] United States |
PMID | 24668609
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Antineoplastic Agents
- Peptides
- Proteasome Inhibitors
- RNA, Small Interfering
- T2635 peptide
- MTOR protein, human
- TOR Serine-Threonine Kinases
- Caspase 3
- Proteasome Endopeptidase Complex
- Sirolimus
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Caspase 3
(metabolism)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects, radiation effects)
- Dose-Response Relationship, Drug
- Drug Synergism
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Neurilemmoma
(drug therapy, pathology, radiotherapy)
- Peptides
(pharmacology)
- Peripheral Nervous System Neoplasms
(drug therapy, pathology, radiotherapy)
- Proteasome Endopeptidase Complex
- Proteasome Inhibitors
(pharmacology, therapeutic use)
- RNA, Small Interfering
(pharmacology)
- Radiation, Ionizing
- Sirolimus
(pharmacology)
- TOR Serine-Threonine Kinases
(genetics, metabolism)
- Transfection
- Xenograft Model Antitumor Assays
|